Clinical Trials Directory

Trials / Unknown

UnknownNCT04535050

DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications

A Prospective, Multicenter, Sham-controlled, Single-blinded, Randomized, Pilot Study to Evaluate the Safety and Effectiveness of DENEX Renal Denervation System in Patients With Uncontrolled Hypertension Not Treated With Anti-HTN Medication

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Kalos Medical · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the safety and effectiveness of renal denervation using DENEX System in patients with hypertension without antihypertensive medication, compared with the sham group.

Detailed description

DENEX system developed by Kalos Medical Inc. is a renal denervation system to efficiently block the sympathetic nerve of the kidney with minimal invasive procedure. It was developed to block the sympathetic nerves distributed in blood vessel wall by delivering high frequency energy to the renal artery for the purpose of treating hypertension.

Conditions

Interventions

TypeNameDescription
DEVICERenal denervationRenal Denervation: DENEX system
PROCEDURERenal angiographyRenal angiography

Timeline

Start date
2022-10-20
Primary completion
2023-12-30
Completion
2026-04-15
First posted
2020-09-01
Last updated
2023-03-20

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04535050. Inclusion in this directory is not an endorsement.